FDA Spotlights 'Prominent Risks' Of Cameron Defibrillator
Boston Scientific Corp., which is betting up to $1.3 billion on a Cameron Health Inc. defibrillator implant, received mixed feedback Monday on the device's safety and effectiveness from the U.S. Food...To view the full article, register now.
Already a subscriber? Click here to view full article